TY - JOUR
T1 - Platelet interactions with liposomes carrying recombinant platelet membrane glycoproteins or fibrinogen
T2 - Approach to platelet substitutes
AU - Nishiya, Takako
AU - Kainoh, Mie
AU - Murata, Mitsuru
AU - Handa, Makoto
AU - Ikeda, Yasuo
N1 - Funding Information:
This work was supported by Health Science Research Grants, Research on Advanced Medical Technology, Ministry of Health and Welfare, Japan. We thank the Welfide Corporation (Osaka, Japan) for preparation of rGPIba and vWf.
PY - 2001
Y1 - 2001
N2 - Liposomes carrying both recombinant platelet membrane glycoproteins GPIa/IIa (rGPIa/IIa) and GPIbα (rGPIbα) (rGPIa/IIa-Ibαliposomes), or fibrinogen (Fbg-liposomes) were prepared. Their interactions with platelets on a collagen surface under flow conditions were evaluated using a recirculating flow chamber, mounted on an epifluorescence microscope, which allows for real-time visualization of fluorescence-labeled liposomes or platelets, interacting with the surface. Adhesion of platelets to the collagen surface increased with increasing the shear rate from 600 to 2400 s-1. Also, the percentages of surface coverage of rGPIa/IIa-Ibα-liposomes or Fbg-liposomes increased with increasing platelet adhesion. These phenomena were attenuated by a peptide containing arginine-glycine-aspartic acid (RGD-peptide), or prostaglandin E1 (PGE), but not by a peptide containing arginine-glycine-glutamic acid (RGE-peptide). In a homogeneous solution, rGPIa/IIa-Ibαliposomes and Fbg-liposomes enhanced platelet aggregation in a dose-dependent manner, as evaluated using an aggregometer. These findings suggest that rGPIa/IIa-Ibα-liposomes and Fbgliposomes form aggregates at the site of injury in blood vessels, resulting in stationary adhesion together with activated platelets.
AB - Liposomes carrying both recombinant platelet membrane glycoproteins GPIa/IIa (rGPIa/IIa) and GPIbα (rGPIbα) (rGPIa/IIa-Ibαliposomes), or fibrinogen (Fbg-liposomes) were prepared. Their interactions with platelets on a collagen surface under flow conditions were evaluated using a recirculating flow chamber, mounted on an epifluorescence microscope, which allows for real-time visualization of fluorescence-labeled liposomes or platelets, interacting with the surface. Adhesion of platelets to the collagen surface increased with increasing the shear rate from 600 to 2400 s-1. Also, the percentages of surface coverage of rGPIa/IIa-Ibα-liposomes or Fbg-liposomes increased with increasing platelet adhesion. These phenomena were attenuated by a peptide containing arginine-glycine-aspartic acid (RGD-peptide), or prostaglandin E1 (PGE), but not by a peptide containing arginine-glycine-glutamic acid (RGE-peptide). In a homogeneous solution, rGPIa/IIa-Ibαliposomes and Fbg-liposomes enhanced platelet aggregation in a dose-dependent manner, as evaluated using an aggregometer. These findings suggest that rGPIa/IIa-Ibα-liposomes and Fbgliposomes form aggregates at the site of injury in blood vessels, resulting in stationary adhesion together with activated platelets.
UR - http://www.scopus.com/inward/record.url?scp=0035674674&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0035674674&partnerID=8YFLogxK
U2 - 10.1081/BIO-100108550
DO - 10.1081/BIO-100108550
M3 - Article
C2 - 11795631
AN - SCOPUS:0035674674
SN - 2169-1401
VL - 29
SP - 453
EP - 464
JO - Artificial Cells, Nanomedicine and Biotechnology
JF - Artificial Cells, Nanomedicine and Biotechnology
IS - 6
ER -